EU requires that Albervi discloses more Ada Mibu's clinical information

2016-06-24

  Albervis's rheumatoid arthritis drug Adam monoclonal antibody is the best -selling prescription medicine in the world，But the EU Supervisory Commissioner pointed out，The details of the clinical trials of the drug are still hidden for no reason。 Ada Ming Mingji has been the focus of information on the open and transparent action of information，Although the European Pharmaceutical Bureau (EMA) is conducting plans to ask for public information，But Albervi has always kept confidential data。Two years ago，EMA agrees with the relevant data of the drug，Albervi filed a prosecution for this，Although the last litigation stake sports betting appis stake sports betting appnot held，But EMA finally announced some of these data。...